deltatrials
Completed PHASE2 NCT00247169

Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II

Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II: A Phase II Trial

Sponsor: Medical University of Vienna

Conditions Cervical Intraepithelial Neoplasia
Interventions progesterone
Updated 5 times since 2017 Last updated: Mar 8, 2012 Started: Aug 31, 2004 Primary completion: Apr 30, 2009 Completion: Apr 30, 2010

Listed as NCT00247169, this PHASE2 trial focuses on Cervical Intraepithelial Neoplasia and remains completed. Sponsored by Medical University of Vienna, it has been updated 5 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical University of Vienna
Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Vienna, Austria